Align Technology, Inc. (ALGN) FinancialsALGNFinancialAlign Technology, Inc.

Align Technology, Inc. (ALGN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Clear Aligner, accounting for 79.5% of total sales, equivalent to $804.62M. Another important revenue stream is Systems and Services. Understanding this composition is critical for investors evaluating how ALGN navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Align Technology, Inc. maintains a gross margin of 72.82%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 19.42%, while the net margin is 10.25%. These profitability ratios, combined with a Return on Equity (ROE) of 10.16%, provide a clear picture of how effectively ALGN converts its operational activities into shareholder value.

In the context of the broader market, ALGN competes directly with industry leaders such as GMED and GKOS. With a market capitalization of $12.88B, it holds a leading position in the sector. When comparing efficiency, ALGN's gross margin of 72.82% stands against GMED's 65.68% and GKOS's 81.67%. Such benchmarking helps identify whether Align Technology, Inc. is trading at a premium or discount relative to its financial performance.

Align Technology has shown a gross margin of 72.82% in Q2 2026, indicating strong profitability. The forward P/E ratio is 14.08, suggesting that the stock may be undervalued relative to its earnings potential.